Hao Lin

4.4k citations
205 papers · 3.0k · 1 hit paper · h-index 28

Impact in

Papers in

Hao Lin

194 papers receiving 3.0k citations

Hao Lin's Hit Papers

Irisin ameliorates doxorubicin-induced cardiac perivascular fibrosis through inhibiting endothelial-to-mesenchymal transition by regulating ROS accumulation and autophagy disorder in endothelial cells 2021 · 149 citations
1490+1+3Years since publication4080120

Peers

Hao Lin
Comparison fields: 5 of 122
  • Obstetrics and Gynecology 560
  • Reproductive Medicine 373
  • Cancer Research 253
  • Epidemiology 429
  • Hepatology 90
Replace Shinichi Ishioka with:
Shinichi Ishioka Japan
Felix Offner Austria
Jesse W. Williams United States
Qurratulain Hasan India
Hirohiko Yamabe Japan
Giovanni Muzzonigro Italy
Maria M. Rodríguez United States
Andrew Lai United States
Christian Radmayr Austria
Ching‐Yuang Lin Taiwan
Hao Lin relative to Shinichi Ishioka Japan Shinichi Ishioka's profile →
Citations per field
00.5×5.5×
Shinichi Ishioka · 1×
Citations per year

Countries citing papers authored by Hao Lin

Since Specialization
Citations

This map shows the geographic impact of Hao Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Lin more than expected).

Fields of papers citing papers by Hao Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Lin. The network helps show where Hao Lin may publish in the future.

Co-authors

The 25 scholars most cited alongside Hao Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hao Lin Line = papers co-authored together Hao Lin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 205 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Irisin ameliorates doxorubicin-induced cardiac perivascular fibrosis through inhibiting endothelial-to-mesenchymal transition by regulating ROS accumulation and autophagy disorder in endothelial cells
Hit paper breakdown →
2021149
2 2017129
3 2017114
4 2002113
5 201394
6 201192
7 200567
8 201565
9 201763
10 201959
11 200452
12 202152
13 202351
14 201137
15 201737
16 202236
17 201935
18 201034
19 201232
20 200032

About Hao Lin

Hao Lin is a scholar working on Obstetrics and Gynecology, Reproductive Medicine, Pulmonary and Respiratory Medicine, Surgery and Epidemiology, having authored 205 papers that have together received 3.0k indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (39 papers), Ovarian cancer diagnosis and treatment (35 papers), Cervical Cancer and HPV Research (15 papers), Uterine Myomas and Treatments (8 papers), Sarcoma Diagnosis and Treatment (6 papers), Colorectal and Anal Carcinomas (5 papers), Cerebrovascular and Carotid Artery Diseases (5 papers) and Maternal and fetal healthcare (5 papers). The work is most often cited by research in Obstetrics and Gynecology (560 citations), Reproductive Medicine (373 citations), Cancer Research (253 citations), Epidemiology (429 citations) and Hepatology (90 citations). Hao Lin has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Chan‐Chao ChangChien, Yu‐Che Ou, Eng‐Yen Huang, Jianan Pan, Hung‐Chun Fu, Junfeng Zhang, Chen‐Hsuan Wu, Jun Gu, Changqian Wang and Kuo‐Chung Lan. Their work appears in journals such as Gynecologic Oncology, International Journal of Gynecological Cancer, Acta Obstetricia Et Gynecologica Scandinavica, Journal of Clinical Oncology and Cancers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact